EPPIN PHARMA, INC.
Biotech · Private
Non-hormonal oral male contraceptive small molecule pharmaceutical
- Grants
- $3.6M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420152016201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Contraceptive testing for semen availability in male monkeys | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Testing a male oral contraceptive targeting Eppin | $1,097,562 | |
| Federal grant | Department of Health and Human Services · Phase I · Drug Interactions in vitro for EP055: a Non-Hormonal Male Contraceptive | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Testing a male oral contraceptive targeting Eppin | $735,059 | |
| Federal grant | Department of Health and Human Services · Phase II · EP055, a non-hormonal male contraceptive:IND-enabling studies | $692,614 | |
| Federal grant | Department of Health and Human Services · Phase II · EP055, a non-hormonal male contraceptive:IND-enabling studies | $602,521 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1108 | EUGIT THERAPEUTICS, INC. | — | — |
| 1109 | Proximity Biosciences LLC | — | — |
| 1110 | EMMUNE INC | — | — |
| 1111 | EPPIN PHARMA, INC. | — | — |
| 1112 | DiaMedica Therapeutics Inc. | — | $110M |
| 1113 | JUN INNOVATIONS INC | — | — |
| 1114 | COMPANION SCIENCES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Method And Compositions For Use In Providing Male Contraceptionapplication
- Method And Compositions For Use In Providing Male Contraceptionapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.